Literature DB >> 2692254

Designing antisense oligonucleotides as pharmaceutical agents.

J S Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2692254     DOI： 10.1016/S0165-6147(89)80004-5

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  5 in total

Review 1.  Genetic engineering of plants for virus resistance.

Authors:  F Gadani; L M Mansky; R Medici; W A Miller; J H Hill
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 2.  Signal transduction pathways: new targets in oncology.

Authors:  R K Sweeb; J H Beijnen
Journal:  Pharm World Sci       Date:  1993-12-17

3.  Specific inhibition of IgE antibody production by an antisense oligodeoxynucleotide oligomer (Oligostick).

Authors:  T J Hall; J Brostoff
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

4.  Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.

Authors:  M I Anazodo; M A Wainberg; A D Friesen; J A Wright
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 5.  Use of Protamine in Nanopharmaceuticals-A Review.

Authors:  Ivana Ruseska; Katja Fresacher; Christina Petschacher; Andreas Zimmer
Journal:  Nanomaterials (Basel)       Date:  2021-06-07       Impact factor: 5.076
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.